Patent License Agreement

The National Institute of Allergy and Infectious Diseases (NIAID) intends to procure a patent license agreement from Polyplus-Transfection, Bioparc, Boulevard Sebastien Brant 67401 Illkirch Graffenstaden, France. Polyplus-Transfection is the only vendor with the US Patent No. 6,013,240 covering DNA transfection techniques. This will be a firm fixed price contract in accordance with the statutory authority for this sole source requirement 41 U.S.C. 253 (c) (1) as implemented by FAR 6.302-1 only one source available, no substitutions possible, and this item contains proprietary data/patent information. THIS ANNOUNCEMENT CONSTITUTES THE ONLY SOLICITATION; QUOTATIONS ARE NOT BEING REQUESTED, AND A WRITTEN SOLICITATION WILL NOT BE ISSUED. The incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAC 2005-70, dated December 15, 2014. The associated North American Industry Classification System (NAICS) Code is 533110, which has a size standard of 7.0 in millions of dollars. All responsible sources who feel they can meet these requirements shall submit an offer that will be considered by the Agency. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Offers must be submitted no later than 5:00 P.M. Eastern Standard Time Monday, December 29, 2014 through the U.S. Postal Service at the address of NIH/NIAID/AMOB, 5601 Fishers Lane, Room 3B24, Rockville, MD 20852-9822. Email and fax submissions are acceptable. Point of contact concerning this requirement is James Kish, who can be reached by phone at 240-669-5110, or e-mailed to kishj@niaid.nih.gov.